BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 3298122)

  • 81. Etiology and pathogenesis of insulin dependent diabetes mellitus.
    Skyler JS; Rabinovitch A
    Pediatr Ann; 1987 Sep; 16(9):682-3, 686-92. PubMed ID: 3309846
    [No Abstract]   [Full Text] [Related]  

  • 82. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus.
    Sigurdsson E; Baekkeskov S
    Curr Top Microbiol Immunol; 1990; 164():143-68. PubMed ID: 2073783
    [No Abstract]   [Full Text] [Related]  

  • 83. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus.
    Mandrup-Poulsen T; Helqvist S; Mølvig J; Wogensen LD; Nerup J
    Autoimmunity; 1989; 4(3):191-218; discussion 219-34. PubMed ID: 2491648
    [No Abstract]   [Full Text] [Related]  

  • 84. [Clinical spectrum of type 1 diabetes mellitus of autoimmune origin].
    Pánczél P; Halmos T
    Orv Hetil; 1988 Feb; 129(9):439-43. PubMed ID: 3282209
    [No Abstract]   [Full Text] [Related]  

  • 85. Cytokines and the pathogenesis of insulin-dependent diabetes mellitus.
    Brouhard BH
    Cleve Clin J Med; 1992; 59(6):629-33. PubMed ID: 1424073
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Immunology and autoimmunity in insulin-dependent (type I) diabetes].
    Sundkvist G; Landin-Olsson M; Lernmark A
    Nord Med; 1988; 103(12):340-2. PubMed ID: 3059325
    [No Abstract]   [Full Text] [Related]  

  • 87. Islet cell antibodies and cellular immunity in human diabetes.
    Papadopoulos G; Lernmark A
    Behring Inst Mitt; 1984 Jul; (75):50-7. PubMed ID: 6435595
    [No Abstract]   [Full Text] [Related]  

  • 88. [The antigenicity of insulin and the autoimmune genesis of diabetes mellitus].
    Henes SH
    Fiziol Zh; 1975; 21(4):552-62. PubMed ID: 767164
    [No Abstract]   [Full Text] [Related]  

  • 89. Immunologic factors in pathogenesis and treatment of human and animal diabetes.
    Naji A; Silvers WK; Bartlett ST; Francfort J; Barker CF
    World J Surg; 1984 Apr; 8(2):214-20. PubMed ID: 6730518
    [No Abstract]   [Full Text] [Related]  

  • 90. [Immunotherapeutic management of juvenile diabetes mellitus].
    Moncada E
    Rev Esp Fisiol; 1989; 45 Suppl():301-8. PubMed ID: 2701766
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Type I insulin-dependent diabetes mellitus: a model for autoimmune polygenic disorders.
    Winter WE
    Adv Dent Res; 1996 Apr; 10(1):81-7. PubMed ID: 8934932
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Type I diabetes mellitus.
    Pigrau C; Lorente A; Martinez-Vazquez JM
    N Engl J Med; 1986 Dec; 315(24):1552. PubMed ID: 3537788
    [No Abstract]   [Full Text] [Related]  

  • 93. Thymus allografts fail to improve lymphopenia or prevent autoimmune diabetes in the BB rat.
    Brayman KL; Deaton D; Barker CF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):218-9. PubMed ID: 2705223
    [No Abstract]   [Full Text] [Related]  

  • 94. [Autoimmune processes in diabetes].
    Kośmider S; Kaszubowski P
    Wiad Lek; 1977 Mar; 30(5):367-70. PubMed ID: 322391
    [No Abstract]   [Full Text] [Related]  

  • 95. Transgenic models of diabetes.
    Sarvetnick N
    Curr Opin Immunol; 1989-1990 Apr; 2(4):604-6. PubMed ID: 2517914
    [No Abstract]   [Full Text] [Related]  

  • 96. Celiac disease and insulin-dependent diabetes mellitus--no proof for a causal association.
    Dahlqvist G
    Acta Paediatr; 1995 Dec; 84(12):1337-8. PubMed ID: 8645946
    [No Abstract]   [Full Text] [Related]  

  • 97. On the pathogenesis of human type I diabetes: where do we stand?
    Bottazzo GF; Todd I; Schwarz G; Gale EM; Pujol-Borrell R
    Ann Inst Pasteur Immunol; 1987; 138(1):117-23. PubMed ID: 3555538
    [No Abstract]   [Full Text] [Related]  

  • 98. Ciclosporin treatment in experimental autoimmune myasthenia gravis.
    Gunn HC; Hiestand PC; Hanglow AC
    Monogr Allergy; 1988; 25():96-107. PubMed ID: 3262820
    [No Abstract]   [Full Text] [Related]  

  • 99. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus.
    Boitard C; Bach JF
    Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326
    [No Abstract]   [Full Text] [Related]  

  • 100. Regulatory T cell control of autoimmune destruction of beta cells in the BB rat.
    Greiner DL; Angelillo M; Mordes JP; Handler ES; Mojcik CF; Nakamura N; Rossini AA
    Adv Exp Med Biol; 1988; 246():379-85. PubMed ID: 3266909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.